Lipidio Pharmaceuticals is a company that is focused on advancing a molecule to treat diseases associated with excess body fat. Its product GDD3898 is developed to treat diseases such as nonalcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain.